Weekly methotrexate versus daily isotretinoin to treat moderate-to-severe chronic plaque psoriasis: a comparative study

Journal Title: Nasza Dermatologia Online - Year 2015, Vol 6, Issue 4

Abstract

 Introduction: There is paucity of data on efficacy of isotretinoin versus methotrexate in psoriasis patients. Aims: We compared the efficacy and safety of once a week methotrexate and daily isotretinoin for the treatment of moderateto-severe chronic plaque psoriasis. Methods: 43 (M: F 30:13) consenting patients having moderate-to-severe chronic plaque psoriasis were divided on alternate basis in Group-A for treatment with methotrexate (15mg/week) and Group-B for isotretinoin (30mg/d) therapy. The clinical response was assessed by the percentage reduction in the baseline PASI scores during next 12 weeks. Results: 14 patients in Group-A and 11 patients in Group-B completed the study. The mean percentage reduction in the PASI score was 79.78 ± 20.68 in the methotrexate group and 51.92 ± 23.83 in the isotoin group at the end of 12 weeks. Five patients in Group-A achieved >75% reduction in the PASI score, while only 3 patients in Group-B showed similar results at the end of 12 weeks signifying faster disease clearance with methotrexate. Isotretinoin-related serious adverse effects were fewer and did not warrant treatment discontinuation. Conclusions: Isotretinoin may be an option for alternative therapy in patients who cannot afford acetretin, are intolerant to methotrexate, have achieved its cumulative dose, or in rotational therapy.

Authors and Affiliations

C Abhinav, Vikram Mahajan, Karaninder Mehta, Pushpinder Chauhan, Mrinal Gupta, Ritu Rawat

Keywords

Related Articles

Stewart Bluefarb syndrome: case report of a rare variant of acroangiodermatitis

Stewart Bluefarb syndrome is a rare acroangiodermatitis which occurs due to presence of arteriovenous malformations. It presents at birth or during early childhood as an erythematous to violaceous plaques over the dorsum...

 Based to clinical case. von Hiplea-Lindau syndrome

von Hippel-Lindau syndrome (VHL) is a rare, genetic multi-system disorder characterized by the abnormal growth of tumors in certain parts of the body (angiomatosis). The tumors of the central nervous system (CNS) are ben...

Slim belt induced morphea-Price paid for a slimmer look

Morphea, also known as localized scleroderma, encompasses a group of distinct conditions characterized by sclerosis of the skin and the underlying tissues. Many triggering factors have been implicated in the development...

Download PDF file
  • EP ID EP148522
  • DOI 10.7241/ourd.20154.106
  • Views 59
  • Downloads 0

How To Cite

C Abhinav, Vikram Mahajan, Karaninder Mehta, Pushpinder Chauhan, Mrinal Gupta, Ritu Rawat (2015).  Weekly methotrexate versus daily isotretinoin to treat moderate-to-severe chronic plaque psoriasis: a comparative study. Nasza Dermatologia Online, 6(4), 392-398. https://europub.co.uk/articles/-A-148522